Kissei Pharmaceutical Co., Ltd. (TSE:4547) announces a share repurchase program. Under the program, the company will repurchase up to 2,000,000 shares, representing 4.34% of its share capital, for ¥6,000 million. The company will repurchase its shares in order to implement a flexible capital policy which responds to changes in the business environment, improve capital efficiency, and enhance shareholder returns.

The repurchase plan will be valid till March 29, 2024 . As of March 31, 2023, the company had 46,115,567 shares outstanding (excluding treasury shares) and 5,695,618 shares in treasury.